AOD-9604s preferential targeting of beta-3 adrenergic receptors, which are highly concentrated in visceral adipose tissue, helps direct that fuel demand toward the fat stores that matter most for health outcomes
Intranasal administration, though less studied with Dihexa specifically, would theoretically provide the most direct CNS delivery with minimal systemic exposurepotentially requiring even less frequent dosing to maintain effective brain tissue concentrations
While individual responses vary and no universally standardized protocol exists, research and practical experience have established reasonable guidelines
The most commonly reported side effects are mild and temporary occasional nausea, flushing, or light stomach discomfort, particularly when starting at higher doses
MP: Conceptualization, Writing review & editing
Side effects are minimal and may include mild soreness at the injection site